Efficacy and Safety of Further Lowering of Low-Density Lipoprotein Cholesterol in Patients Starting With Very Low Levels
Author:
Affiliation:
1. TIMI Study Group, Division of Cardiovascular Medicine, Brigham and Women’s Hospital, Harvard Medical School, Boston, Massachusetts
2. Deputy Editor, JAMA Cardiology
Publisher
American Medical Association (AMA)
Subject
Cardiology and Cardiovascular Medicine
Reference16 articles.
1. Interpretation of the evidence for the efficacy and safety of statin therapy.;Collins;Lancet,2016
2. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines.;Grundy;Circulation,2004
3. Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials.;Baigent;Lancet,2010
4. Preferred Reporting Items for Systematic Reviews and Meta-analyses: the PRISMA statement.;Moher;Ann Intern Med,2009
5. Ezetimibe added to statin therapy after acute coronary syndromes.;Cannon;N Engl J Med,2015
Cited by 163 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Long-Term Evaluation of Lipid Profile Changes in Olympic Athletes;International Journal of Sport Nutrition and Exercise Metabolism;2024-09-01
2. In-silico trial emulation to predict the cardiovascular protection of new lipid-lowering drugs: an illustration through the design of the SIRIUS programme;European Journal of Preventive Cardiology;2024-08-05
3. Low-Density Lipoprotein Cholesterol, Cardiovascular Disease Risk, and Mortality in China;JAMA Network Open;2024-07-18
4. The impact of statin-ezetimibe combination therapy versus statin monotherapy on coronary plaque regression in patients with acute coronary syndrome: a meta-analysis;Journal of the Pakistan Medical Association;2024-07-07
5. Effectiveness of the low‐density lipoprotein cholesterol goals in secondary cardiovascular prevention;European Journal of Clinical Investigation;2024-06-03
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3